Solvonis Therapeutics plc (SVNS)
Market Closed
25 Jun, 15:30
LSE 
0. 19
GBX 0
0%
- Market Cap
- P/E Ratio
- Div Yield
9.35M Volume
- Eps
0.19 GBX
Previous Close Want to track SVNS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Solvonis Therapeutics plc (SVNS) Statistics
Valuation metrics
Market Cap -
Enterprise value 11.22M
Trailing P/E (ttm) -1.6
Forward P/E -
PEG ratio -0.02
Price/Sales (ttm) -
Price/Book (mrq) 1.49
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1.95
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 0.17
52-Week high 0.4
Beta -
50-Day moving average -
200-Day moving average -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.76%
Return on equity -1.24%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 4%
Book value per share (mrq) 0
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
